Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|February 1, 2008
Pyrrolo[2,3-a]carbazoles as potential cyclin dependent kinase 1 (CDK1) Inhibitors. Synthesis, biological evaluation, and binding mode through docking simulationsManolis A Fousteris, Athanasios Papakyriakou, Anna Koutsourea, et al.
International Journal of Molecular Sciences|February 27, 2026
Design, Synthesis, Antiproliferative Potency and In Silico Studies of Novel Alkynyl Quinazolines as Potential EGFR InhibitorsApostolia Gkoutzivelaki, Sotiria-Iro Triantopoulou, Lykourgos Chiniadis, et al.
Scientific Reports|August 14, 2021
The ERAP1 active site cannot productively access the N-terminus of antigenic peptide precursors stably bound onto MHC class IGeorge Mavridis, Anastasia Mpakali, Jerome Zoidakis, et al.
Chemmedchem|November 21, 2015
Synthesis and Biopharmaceutical Evaluation of Imatinib Analogues Featuring Unusual Structural MotifsKyriacos C Nicolaou, Dionisios Vourloumis, Sotirios Totokotsopoulos, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 3, 2015
Probing the mechanism of allylic substitution of Morita-Baylis-Hillman acetates (MBHAs) by using the silyl phosphonite paradigm: scope and applications of a versatile transformationMaria Kalyva, Alexandros L Zografos, Era Kapourani, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2019
Mechanism for antigenic peptide selection by endoplasmic reticulum aminopeptidase 1Petros Giastas, Anastasia Mpakali, Athanasios Papakyriakou, et al.
Nucleic Acids Research|August 13, 2016
Mammalian PNLDC1 is a novel poly(A) specific exonuclease with discrete expression during early developmentDimitrios Anastasakis, Ilias Skeparnias, Athanasios-Nasir Shaukat, et al.
Heliyon|November 17, 2022
Design, synthesis and biological evaluation of new 3,4-dihydroquinoxalin-2(1<i>H</i>)-one derivatives as soluble guanylyl cyclase (sGC) activatorsDionysios-Panagiotis Kintos, Konstantinos Salagiannis, Vasiliki Vazoura, et al.
Oncotarget|April 20, 2017
Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small moleculeOrestis Argyros, Theodoros Karampelas, Aimilia Varela, et al.
Bioorganic Chemistry|October 28, 2022
Peptide inhibitors of angiotensin-I converting enzyme based on angiotensin (1-7) with selectivity for the C-terminal domainRogerio L da Silva, Athanasios Papakyriakou, Adriana K Carmona, et al.
Pageof 10